Compare DexCom, Inc. (DXCM) vs S&P Global Inc (SPGI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs S&P Global Inc — how do they compare? DexCom, Inc. trades at $89.53 (market cap $33.08B), while S&P Global Inc trades at $408.3 (market cap $121.15B). The key difference: S&P Global Inc is far larger — about 3.7× DexCom, Inc.'s market cap, and S&P Global Inc pays a 0.94% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | SPGI | |
|---|---|---|
Market Cap | $33.08B | $121.15B |
Sector | Health | Financials |
52-Week High | $89.53 | $534.79 |
52-Week Low | $54.84 | $370.42 |
Enterprise Value | $32.53B | $132.63B |
Dividend Yield | — | 0.94% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About S&P Global Inc
S&P Global provides data and benchmarks to capital and commodity market participants. In 2021 and excluding IHS Markit, S&P Ratings was over 45% of the firm's revenue and over 55% of the firm's operating income. S&P Ratings is the largest credit rating agency in the world. The firm's other segments include Market Intelligence, Indices, and Platts. Market Intelligence provides desktop tools and other data solutions to investment banks, corporations, and other entities. Indices provides benchmarks for financial markets and is monetized through subscriptions, asset-based fees, and transaction-based royalties. Platts provides benchmarks to commodity markets, principally petroleum.
Read more on SPGI →
